SMMTLawsuits•globenewswire•June 18, 2025 at 03:54 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT

Sentiment:Negative (-50)

Summary

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 18, 2025 by globenewswire